|
Abstract: . . . A. N Engl J Med 2000; 342:334-342, Feb 3, 2000. PROCEEDINGS OF THE 32ND BETHESDA CONFERENCE CARE OF THE ADULT WITH CONGENITAL HEART DISEASE JACC Vol. 37, 2001: 1161-98 Recommendations for Determining Eligibility for Competition in Athletes with Cardiovascular Abnormalities: Bethesda Conference 26 (Revision of Bethesda Conference #16), January 6-7, 1994. (J Am Coll Cardiol 1994;24:845-99) Adults with Congenital Heart Disease . . . . . . Engl J Med 2000; 342:334-342, Feb 3, 2000. PROCEEDINGS OF THE 32ND BETHESDA CONFERENCE CARE OF THE ADULT WITH CONGENITAL HEART DISEASE JACC Vol. 37, 2001: 1161-98 Recommendations for Determining Eligibility for Competition in Athletes with Cardiovascular Abnormalities: Bethesda Conference 26 (Revision of Bethesda Conference #16), January 6-7, 1994. (J Am Coll Cardiol 1994;24:845-99) Adults with Congenital Heart Disease . . . --1962,2,490,1168,9811
|